Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection.
Feline immunodeficiency virus (FIV) infection is characterized by chronic overactivation of immune and inflammatory system, resulting in anergic state and dysfunction of immune cells. Lactoferrin (LF), a glycoprotein present in exocrine secretions and neutrophils, plays an important role in host defense system. Our previous study showed that oral administration of bovine LF (bLF) suppressed oral inflammation, improved the clinical symptoms and decreased serum gamma-globulin as a marker of inflammation in FIV-infected cats with intractable stomatitis. The anti-inflammatory effect was partly involved in regulation of neutrophil function by bLF. In this study, to clarify the relationship between anti-inflammatory effects of bLF and peripheral blood mononuclear cells (PBMC), we examined the effect of bLF on proliferation, cell cycle progression and cytokine expression in mitogen-activated PBMC. MTT [3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl tetrazolium bromide] assay showed that bLF inhibited the concanavalin A (ConA)-induced cell proliferation in FIV-infected cats with the asymptomatic carrier and AIDS-related complex (ARC) phase. Bovine LF restored ConA-induced cell cycle progression and resulted in suppression of the induced apoptosis in feline PBMC. Real-time RT-PCR showed that bLF suppressed ConA-induced expression of interferon-gamma and interleukin-2 in cells of the ARC group regardless of the time of its addition to the medium. These results suggest the hypothesis that therapy with bLF may have the potential to improve and protect functions of overactivated lymphocytes by modulating the cell proliferation, cell cycle and cytokines expression in cats in terminal stage of FIV infection.
Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka, Japan.
Saori
S
Kobayashi
Reeko
R
Sato
Takako
T
Aoki
Katsuhiko
K
Omoe
Osamu
O
Inanami
Careen
C
Hankanga
Yuichi
Y
Yamada
Nobuyuki
N
Tomizawa
Jun
J
Yasuda
Juso
J
Sasaki
D000818:Animals; D002371:Cat Diseases / Q000821:virology*; D002415:Cats; D002417:Cattle; D049109:Cell Proliferation / Q000187:drug effects; D002908:Chronic Disease; D003208:Concanavalin A / Q000494:pharmacology; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D016089:Immunodeficiency Virus, Feline; D007781:Lactoferrin / Q000494:pharmacology*; D016180:Lentivirus Infections / Q000662:veterinary*; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects*; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism
D016207:Cytokines; D012333:RNA, Messenger; D003208:Concanavalin A; D007781:Lactoferrin